Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Shanghai MicroPort MedBot (2252.HK)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (HK$)	Price Target (HK$)	Rating
2022-03-30	25.80	-	No Rating
2023-01-04	32.20	43.00	Buy
2023-04-01	28.25	40.00	Buy
2023-08-31	18.64	36.40	Buy
2024-03-22	13.86	21.90	Buy
2024-04-02	12.72	20.00	Buy
2024-09-11	6.14	9.50	Buy
2025-01-22	10.40	13.00	Buy
2025-03-12	21.90	23.70	Neutral
2025-03-28	17.38	20.50	Neutral

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.